Dysregulated miRNAs, which was identified by our experimental observations and those of other studies [13]–[15], indicate that defects in post-transcriptional regulation contribute to the pathogenesis of metabolic disorders at multiple levels, including impaired insulin signaling, gluconeogenesis, glucose-induced apoptosis and impaired angiogenesis. The gene discussed is INS; the disease is metabolic disease.